
Both Mickey
17 and Novocaine
have been making waves at the box office, each carving its own path to success. Bong Joon-ho’s ambitious sci-fi spectacle Mickey
17 has dazzled audiences with its high-concept storytelling and blockbuster appeal, drawing in impressive crowds. Meanwhile, the indie thriller Novocaine
has been gaining steady traction, surprising many with its sharp execution and growing word-of-mouth buzz. As both films continue to perform well, one cannot help but wonder if an unexpected shift in momentum is on the horizon.
After all, every great story has a twist, and this box-office battle might just be saving its best one for last.
The underdog effect may just give Novocaine the winning edge
The cinematic competition has set its stage, and what a spectacle it has become. Novocaine
, light on its feet, made an early impact with $1.75 million in previews and charged toward a $10 million to $12 million debut.
With an $18 million budget, it proved that a whisper, well-placed, could outlast even the loudest roar. Meanwhile, Mickey
17, a giant weighed down by its own grandeur, found itself stumbling, losing over half its initial force in its second weekend.
‘NOVOCAINE’ made $1.75M in previews and is on track to open with $10M to $12M at the domestic box office.
The film cost $18M to produce. pic.twitter.com/FD6R1ZvxDl
— Film Updates (@FilmUpdates) March 14, 2025
History has favored the unexpected, and time and again, smaller films have outmaneuvered their heavyweight competitors. Joker
turned a $55 million budget into a billion-dollar phenomenon, while Paranormal Activity
transformed a mere $15,000 into a worldwide sensation. Audiences are unpredictable beings, drawn not to spectacle alone but to what truly grips them. Novocaine
has intrigue, strong word-of-mouth, and a momentum that refuses to fade. The tides shift, the whispers grow, and if history is any guide, this contest’s final twist may be on Novocaine
‘s side.
When Novocaine
throws a curveball, it does more than shock- it cements itself as a must-watch, keeping theaters packed.
Novocaine’s shocking twists could make it the clear-cut winner
There is something delightful about a film that refuses to play by the rules. Novocaine
does not just surprise the audience, it leaves them breathless with anticipation. The third act leaves the audience bamboozled, a revelation so wickedly sharp it sends them reeling. Jack Quaid, ever the master of tension, pulls the viewer into his unraveling world, his performance reminiscent of the raw, unhinged energy he brings to The Boys.
#Novocaine is an action comedy crafted with heart and a bloody splash of romance. Inventive fights, good pacing and twists you don’t see coming. Jack Quaid is awesome and lifts the material. Amber Midthunder is charming. The chemistry is delicious. Ray Nicholson is a fun villain. pic.twitter.com/oRlqrOKlBF
— J ♱ (@theprimetimeman) March 14, 2025
This ability to keep viewers guessing has given Novocaine
an edge at the box office. Films that deliver true unpredictability, like Gone Girl
and Fight Club
, have historically thrived on word-of-mouth momentum, sustaining long theatrical runs. With a gripping narrative and a fanbase eager for more, Novocaine
is proving that a well-placed twist can reshape the entire game.
Do you think Novocaine
deserves the box office crown? Drop your take in the comments below!